|
The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q-New prognostic markers are needed
|
Dec 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.
|
Jun 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
The role of T-cells in the pathogenesis of myelodysplastic syndromes: Passengers and drivers
|
Dec 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Question prompt list responds to information needs of myelodysplastic syndromes patients and caregivers
|
Jun 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Aplastic Anemia & MDS International Foundation: Bone marrow failure disease scientific symposium 2012
|
May 2013
|
Leuk Res
|
aplastic anemia
|
|
Prognostic value of telomere attrition in patients with aplastic anemia.
|
May 2013
|
Leuk Res
|
aplastic anemia
|
|
Historical perspectives on myelodysplastic syndromes
|
Aug 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study
|
Mar 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes and autoimmune diseases-Case series and review of literature.
|
May 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Good riddance to the term "refractory anemia" in myelodysplastic syndromes
|
Oct 2016
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
